Retatrutide 40mg Pen Guide: Triple Agonist Protocol, Click Chart & EU Cold-Chain Delivery
Why Retatrutide (LY3437943) surpasses single and dual incretins by activating the glucagon receptor (GCGR) for direct hepatic lipolysis and up to 24.2% weight reduction in phase-2/3 protocols.
GEO: Spain (Marbella, Barcelona), France (Nice, Monaco, Paris), Italy (Milan, Rome), UAE (Dubai)
Scientific Review: Dr. Lukas V. Meyer, Ph.D. (Head of Analytical Chemistry, Synedica Basel R&D)
- Triple receptor activation: GLP-1 (satiety) + GIP (insulin sensitivity) + Glucagon (thermogenesis & lipolysis).
- Precision 60-unit pen format: 4 sterile 10mg cartridges (40mg total) = 1 click equals 0.167 mg.
- Verified 99.54% RP-HPLC purity with batch CoA and scratch-off cryptographic seal.
- Direct 24–48h medical cold-chain delivery across Spain, France, Italy, Cyprus, Germany, and UAE.
Direct Expert Answers (Q&A)
What is Retatrutide and how does it work?
Retatrutide (LY3437943) is a 3rd-generation triple hormone receptor agonist that activates GLP-1, GIP, and Glucagon (GCGR) receptors simultaneously, delivering up to 24.2% weight reduction and clearing >85% of liver fat.
How do you dose a Retatrutide 40mg 60-unit pen?
Each 10mg cartridge has 60 clicks (1 click = 0.167 mg). Inject once weekly: Weeks 1–4 at 2.0 mg (12 clicks), Weeks 5–8 at 4.0 mg (24 clicks), Weeks 9–12 at 6.0–8.0 mg (36–48 clicks).
1. Mechanism of Action: Why 3 Receptors Change Metabolic Research
First-generation incretins like Semaglutide target only the GLP-1 receptor, primarily suppressing appetite and slowing gastric emptying. Second-generation Tirzepatide added GIP co-agonism. Retatrutide represents the third generation by integrating Glucagon Receptor (GCGR) agonism. In clinical studies, GCGR activation increases resting energy expenditure, oxidizes liver fat (resolving hepatic steatosis in >85% of subjects), and prevents the metabolic plateau commonly seen at week 16 of monotherapy.
2. Synedica 60-Unit Pen Titration & Click Conversion Table
Each Synedica Retatrutide 40mg kit contains four 10mg sterile borosilicate cartridges. Because each cartridge is calibrated to 60 dial units (clicks), researchers avoid manual reconstitution errors with bacteriostatic water and insulin syringes:
| Protocol Phase | Weeks | Weekly Dose | Dial Units (Clicks) | Cartridge Yield |
|---|---|---|---|---|
| Phase 1: Receptor Acclimation | Weeks 1–4 | 2.0 mg / week | 12 clicks | 5 weekly doses per cartridge |
| Phase 2: Primary Lipolysis | Weeks 5–8 | 4.0 mg / week | 24 clicks | 2.5 weekly doses per cartridge |
| Phase 3: Deep Metabolic Shift | Weeks 9–12 | 6.0–8.0 mg / week | 36–48 clicks | Full triple-pathway activation |
| Phase 4: Peak Maintenance | Week 13+ | 10.0 mg / week | 60 clicks | 1 full cartridge per week |
3. Cold-Chain Delivery Across Spain, France, Italy & EU
Peptide chains degrade rapidly when exposed to ambient temperatures above 25°C during standard postal transit. Synedica dispatches all European orders from our Amsterdam/Frankfurt depot in vacuum-insulated medical coolers with phase-change gel packs (2°C–8°C for 72 hours) straight to clinics and private clients in Marbella, Barcelona, Madrid, Paris, Nice, Monaco, Milan, Rome, and Berlin.